These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29599759)

  • 1. Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection.
    Lam JKP; Hui KF; Ning RJ; Xu XQ; Chan KH; Chiang AKS
    Front Microbiol; 2018; 9():416. PubMed ID: 29599759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.
    Ning RJ; Xu XQ; Chan KH; Chiang AK
    Immunology; 2011 Oct; 134(2):161-71. PubMed ID: 21896011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis.
    Fischer F; Mücke J; Werny L; Gerrer K; Mihatsch L; Zehetmaier S; Riedel I; Geisperger J; Bodenhausen M; Schulte-Hillen L; Hoffmann D; Protzer U; Mautner J; Behrends U; Bauer T; Körber N
    Virol J; 2024 Jun; 21(1):139. PubMed ID: 38877590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.
    Pender MP; Csurhes PA; Burrows JM; Burrows SR
    Clin Transl Immunology; 2017 Jan; 6(1):e126. PubMed ID: 28197337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ T cell responses to lytic EBV infection: late antigen specificities as subdominant components of the total response.
    Abbott RJ; Quinn LL; Leese AM; Scholes HM; Pachnio A; Rickinson AB
    J Immunol; 2013 Dec; 191(11):5398-409. PubMed ID: 24146041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
    White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ
    Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay.
    Calarota SA; Chiesa A; Zelini P; Comolli G; Minoli L; Baldanti F
    Immunology; 2013 Aug; 139(4):533-44. PubMed ID: 23560877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.
    Meij P; Leen A; Rickinson AB; Verkoeijen S; Vervoort MB; Bloemena E; Middeldorp JM
    Int J Cancer; 2002 May; 99(1):93-9. PubMed ID: 11948498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response.
    Steven NM; Annels NE; Kumar A; Leese AM; Kurilla MG; Rickinson AB
    J Exp Med; 1997 May; 185(9):1605-17. PubMed ID: 9151898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
    Yu HX; Srinivasan N; Ren EE; Chan SH
    Tissue Antigens; 2005 Jun; 65(6):539-43. PubMed ID: 15896201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs.
    Sohn DH; Sohn HJ; Lee HJ; Lee SD; Kim S; Hyun SJ; Cho HI; Cho SG; Lee SK; Kim TG
    PLoS One; 2015; 10(5):e0127899. PubMed ID: 26023769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y; Aïssi-Rothe L; Virion JM; De Carvalho Bittencourt M; Ulas N; Audonnet S; Salmon A; Clement L; Venard V; Jeulin H; Stoltz JF; Decot V; Bensoussan D
    Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G; Pepperl S; Deml L; Modrow S; Wolf H; Jilg W
    Virology; 1999 Nov; 264(2):289-97. PubMed ID: 10562493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients.
    Falco DA; Nepomuceno RR; Krams SM; Lee PP; Davis MM; Salvatierra O; Alexander SR; Esquivel CO; Cox KL; Frankel LR; Martinez OM
    Transplantation; 2002 Aug; 74(4):501-10. PubMed ID: 12352909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.